 Connection
David Moreno to Humans
This is a "connection" page, showing publications David Moreno has written about Humans.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.192 |
|
|
|
-
Moreno DF, Fern?ndez de Larrea C. Clinical Implications of Genomic Profile in Waldenstr?m Macroglobulinemia. Hematol Oncol Clin North Am. 2023 08; 37(4):659-670.
Score: 0.024
-
Moreno DF, L?pez-Guerra M, Paz S, Oliver-Cald?s A, Mena MP, Correa JG, Battram AM, Osuna M, Rivas-Delgado A, Rodr?guez-Lobato LG, Card?s O, Tovar N, Cibeira MT, Jim?nez-Segura R, Blad? J, Rosi?ol L, Colomer D, Fern?ndez de Larrea C. Prognostic impact of MYD88 and CXCR4 mutations assessed by droplet digital polymerase chain reaction in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenstr?m macroglobulinaemia. Br J Haematol. 2023 01; 200(2):187-196.
Score: 0.023
-
Moreno DF, de Larrea CF, Castillo JJ. New treatment strategies for Waldenstr?m macroglobulinemia. Clin Adv Hematol Oncol. 2022 Aug; 20(8):506-515.
Score: 0.023
-
Torner F, Nu?ez JH, Inarejos Clemente EJ, Garraus M, Su?ol M, Mart?nez AD, Moreno D. Total calcaneal allograft reconstruction of an Ewing's sarcoma in a child: Outcome and review of the literature. Cancer Rep (Hoboken). 2022 09; 5(9):e1626.
Score: 0.022
-
Moreno DF, Clap?s V, Soler JA, Gonz?lez-Montes Y, Gironella M, Motll? C, Granell M, Abella E, Garc?a-Pintos M, Garc?a-Gui??n A, Cabezudo E, Blad? J, Rosi?ol L. Real-World Evidence of Daratumumab Monotherapy in Relapsed/Refractory Multiple Myeloma Patients and Efficacy on Soft-Tissue Plasmacytomas. Clin Lymphoma Myeloma Leuk. 2022 08; 22(8):635-642.
Score: 0.022
-
Moreno DF, Cid J. Graft-versus-host disease. Med Clin (Barc). 2019 01 04; 152(1):22-28.
Score: 0.017
-
Pijuan J, Moreno DF, Yahya G, Moisa M, Ul Haq I, Krukiewicz K, Mosbah R, Metwally K, Cavalu S. Regulatory and pathogenic mechanisms in response to iron deficiency and excess in fungi. Microb Biotechnol. 2023 11; 16(11):2053-2071.
Score: 0.006
-
Jim?nez-Segura R, Rosi?ol L, Cibeira MT, Fern?ndez de Larrea C, Tovar N, Rodr?guez-Lobato LG, Blad? E, Moreno DF, Oliver-Cald?s A, Blad? J. Paraskeletal and extramedullary plasmacytomas in multiple myeloma at diagnosis and at first relapse: 50-years of experience from an academic institution. Blood Cancer J. 2022 09 16; 12(9):135.
Score: 0.006
-
Oliver-Caldes A, Jim?nez R, Espa?ol-Rego M, Cibeira MT, Ortiz-Maldonado V, Quintana LF, Castillo P, Guijarro F, Tovar N, Montoro M, Benitez-Ribas D, Bataller A, Gonz?lez-Navarro EA, Cid J, Lozano M, Perez-Amill L, Martin-Antonio B, Mena MP, Moreno DF, Rodr?guez-Lobato LG, Campistol JM, Calvo G, Blad? J, Rosi?ol L, Juan M, Pascal M, Urbano-Ispizua A, Fern?ndez de Larrea C. First report of CART treatment in AL amyloidosis and relapsed/refractory multiple myeloma. J Immunother Cancer. 2021 12; 9(12).
Score: 0.005
-
Isola I, Bras?-Maristany F, Moreno DF, Mena MP, Oliver-Calders A, Par? L, Rodr?guez-Lobato LG, Martin-Antonio B, Cibeira MT, Blad? J, Rosi?ol L, Prat A, Lozano E, Fern?ndez de Larrea C. Gene Expression Analysis of the Bone Marrow Microenvironment Reveals Distinct Immunotypes in Smoldering Multiple Myeloma Associated to Progression to Symptomatic Disease. Front Immunol. 2021; 12:792609.
Score: 0.005
-
Rodr?guez-Lobato LG, Pereira A, Fern?ndez de Larrea C, Cibeira MT, Tovar N, Jim?nez-Segura R, Moreno DF, Oliver-Cald?s A, Rosi?ol L, Blad? J. Real-world data on survival improvement in patients with multiple myeloma treated at a single institution over a 45-year period. Br J Haematol. 2022 02; 196(3):649-659.
Score: 0.005
-
Isola I, Moreno DF, Moga E, Mena MP, Tovar N, Rodr?guez-Lobato LG, Oliver-Cald?s A, Salgado MC, Bras?-Maristany F, Yag?e J, Cibeira MT, Prat A, Rosi?ol L, Blad? J, Fern?ndez de Larrea C. Immunoparesis defined by heavy/light chain pair suppression in smoldering multiple myeloma shows initial isotype specificity and involves other isotypes in advanced disease. Ann Hematol. 2021 Dec; 100(12):2997-3005.
Score: 0.005
-
Yahya G, P?rez AP, Mendoza MB, Parisi E, Moreno DF, Art?s MH, Gallego C, Aldea M. Stress granules display bistable dynamics modulated by Cdk. J Cell Biol. 2021 03 01; 220(3).
Score: 0.005
-
Luo X, Song R, Moreno DF, Ryu HY, Hochstrasser M, Acar M. Epigenetic Mechanisms Contribute to Evolutionary Adaptation of Gene Network Activity under Environmental Selection. Cell Rep. 2020 10 27; 33(4):108306.
Score: 0.005
-
Rodr?guez-Lobato LG, Mart?nez-Roca A, Moreno DF, Guti?rrez-Garc?a G, Su?rez-Lled? M, Rovira M, Mart?nez C, Rosi?ol L, Almeida Jorge AS, Pedraza A, Cardozo C, Puerta-Alcalde P, Garcia-Vidal C, Mar?n P, Cid J, Lozano M, Gallego C, Hernando A, Segura S, Urbano-Ispizua ?, Fern?ndez-Avil?s F. Impact of intensifying primary antibiotic prophylaxis in at-home autologous stem cell transplantation program for lymphoma patients. Leuk Lymphoma. 2020 07; 61(7):1565-1574.
Score: 0.005
-
Castillo JJ, Moreno DF, Arbelaez MI, Hunter ZR, Treon SP. CXCR4 mutations affect presentation and outcomes in patients with Waldenstr?m macroglobulinemia: A systematic review. Expert Rev Hematol. 2019 10; 12(10):873-881.
Score: 0.005
-
Cid J, Carbass? G, Su?rez-Lled? M, Moreno DF, Mart?nez C, Guti?rrez-Garc?a G, Fern?ndez-Avil?s F, Rosi?ol L, Giavedoni P, Mascar? JM, Agust? C, Mar?n P, Rovira M, Urbano-Ispizua ?, Lozano M. Efficacy and safety of one-day offline extracorporeal photopheresis schedule processing one total blood volume for treating patients with graft-versus-host disease. Transfusion. 2019 08; 59(8):2636-2642.
Score: 0.005
-
Tagarro A, Otheo E, Baquero-Artigao F, Navarro ML, Velasco R, Ruiz M, Pen?n M, Moreno D, Rojo P, Madero R. Dexamethasone for Parapneumonic Pleural Effusion: A Randomized, Double-Blind, Clinical Trial. J Pediatr. 2017 06; 185:117-123.e6.
Score: 0.004
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|